Synapse Drugs Private Limited
About Synapse Drugs Private Limited
Data last updated:
Synapse Drugs Private Limited is a private limited company based in Secunderabad, Telangana, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the general construction services segment of the infrastructure and utilities sector. It was incorporated on 03 December 2014.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096661.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sucharitha Vala and Niranjanrao Janardhanrao Errabelli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No. 1 – 8 – 309/1 Flat No. 205 Lake View Residency Patigadda, Secunderabad, Telangana, India – 500003.
Company details
Contact details
Synapse Drugs Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 1 – 8 – 309/1 Flat No. 205 Lake View Residency Patigadda, Secunderabad, Telangana, India – 500003
- IndustryInfrastructure and Utilities, General Construction Services
To see the full contact details of Synapse Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synapse Drugs is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
Financials of Synapse Drugs Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synapse Drugs Private Limited, buy the company report.
Board of directors of Synapse Drugs Private Limited
Synapse Drugs has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sucharitha Vala Also directs: Uma Kanmanthreddy Estates LLP, Yamini Films Private Limited | Director | 01 May 2019 | 7 Years 5 Months | Current |
| Niranjanrao Janardhanrao Errabelli | Director | 03 Dec 2014 | 11 Years 10 Months | Current |
| Venkata Narasimha Rao Vala Also directs: Uma Kanmanthreddy Estates LLP, Bvslh Estates LLP | Director | 03 Dec 2014 | 11 Years 10 Months | Current |
Auditor
Synapse Drugs Private Limited is audited by SAYA REDDY & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAYA REDDY & ASSOCIATES | FY 2020 | 005122S |
Shareholding
The shareholding of Synapse Drugs Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synapse Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synapse Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synapse Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Synapse Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Synapse Drugs Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Niranjanrao Janardhanrao Errabelli ceased to be Director on 08 Nov 2025.
Frequently asked questions
Synapse Drugs is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Synapse Drugs is a company pending strike off, currently registered as a private limited company based in Secunderabad, Telangana, India. The company works in general construction services, within the infrastructure and utilities industry. It was incorporated on 03 December 2014 and is registered under CIN U24232TG2014PTC096661. The company may be struck off soon - caution is advised.
The compliance status of Synapse Drugs is compliant as of 23 July 2026.
Synapse Drugs has 3 current directors:
- Sucharitha Vala - Director
- Niranjanrao Janardhanrao Errabelli - Director
- Venkata Narasimha Rao Vala - Director
The CIN (Corporate Identification Number) of Synapse Drugs is U24232TG2014PTC096661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synapse Drugs was incorporated on 03 December 2014. It is registered with the Registrar of Companies, Hyderabad.
The registered office of Synapse Drugs is at H.No. 1 – 8 – 3091 Flat No. 205 Lake View Residency Patigadda, Secunderabad, Telangana, India – 500003.
The latest financial statements of Synapse Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
Synapse Drugs operates in the infrastructure and utilities industry, in the general construction services segment.
Niranjanrao Janardhanrao Errabelli ceased to be Director on 08 Nov 2025. Sucharitha Vala ceased to be Additional Director on 26 Sep 2019. Sucharitha Vala was appointed as Director on 01 May 2019. Synapse Drugs has 5 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
